search
Back to results

Evaluation in Vivo of Mouthwash With Nanoencapsulated Fluoride

Primary Purpose

Dental Caries

Status
Completed
Phase
Phase 3
Locations
Brazil
Study Type
Interventional
Intervention
Mouthwash 100% Nano-F
Mouthwash 50% Nano-F
Mouthwash standard
Placebo
Sponsored by
Fabio Correia Sampaio
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dental Caries focused on measuring Fluoride, Dental caries, Mouthwashes

Eligibility Criteria

18 Years - 32 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • resident in João Pessoa;
  • Decayed, Missing, Filled Index<6;
  • Healthy

Exclusion Criteria:

  • orthodontic treatment;
  • gingivitis;
  • Periodontal disease;
  • Smokers;
  • Present active tooth decay;
  • Tooth sensitivity;
  • Those undergoing treatment with fluoride products and / or use of antimicrobials in the past four weeks

Sites / Locations

  • Federal University of Paraíba

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Placebo Comparator

Active Comparator

Experimental

Experimental

Arm Label

Placebo

Mouthwash standard

Mouthwash 50% Nano-F

Mouthwash 100% Nano-F

Arm Description

Mouthwash without fluoride.

Mouthwash with 225ppm sodium fluoride (NaF). Positive control.

Mouthwash experimental with Fluoride being half of fluoride Nanoencapsulated and other half freeform of NaF.

Mouthwash experimental with fluoride 100% Nanoencapsulated.

Outcomes

Primary Outcome Measures

Bioavailability of intraoral fluoride (biofilm and saliva) collection of dental plaque(biofilm) and saliva

Secondary Outcome Measures

Full Information

First Posted
November 18, 2021
Last Updated
November 18, 2021
Sponsor
Fabio Correia Sampaio
search

1. Study Identification

Unique Protocol Identification Number
NCT05143086
Brief Title
Evaluation in Vivo of Mouthwash With Nanoencapsulated Fluoride
Official Title
Evaluation in Vivo of Experimental Mouthwash With Nanoencapsulated Fluoride
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
November 1, 2016 (Actual)
Primary Completion Date
November 15, 2017 (Actual)
Study Completion Date
December 20, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Fabio Correia Sampaio

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The literature recognizes that fluoride is the most widely used and studied means for dental remineralization. The use of fluoride mouthwashes is shown as an effective way to increase the fluoride intraoral availability. However, the current challenge is the substantivity, so new compounds have been introduced into these formulations. This study aims to evaluate the in vivo effect of fluoride mouthwash containing nanoencapsulated Fluoride (NanoF) - in fluoride retention in saliva and dental plaque. A study of the clinical and laboratory type, crossover, double-blind, randomized will be held. After sample calculation, the total of 12 individuals aged between 18 and 35 years old, healthy, decayed, missing, and filled teeth index less than 6 and residents in brazilian northeast capital will be part of the sample. Fluoride bioavailability will be evaluated in the biofilm and saliva after the use of fluoridated weekly. The biofilm will be assessed on 1h and 12 h after rinsing; and unstimulated saliva in times of 3, 15, 30, 45, 60 minutes and 12 hours after. It will be 3 mouthwashes: 50% Nanoencapsulated Fluoride, 100% Nanoencapsulated Fluoride and Free sodium fluoride. Between weeks of use, rinsing will be extended washout (without fluoride) to avoid carryover effect. Inferential data analysis will be carried out, considering the amount of alpha <0.05. So knowing that caries is a dynamic process, the largest fluoride retention in the oral fluids promoted by the Nanoencapsulated Fluoride may have important impact on Des-Re process and in the control of dental caries.
Detailed Description
Study design It is a quantitative study of double-blind randomized crossover clinical type with inductive approach and documentation of technical and direct observation with measurements in the laboratory. In order to assess the bioavailability of intraoral fluoride week after the use of fluoride mouthwashes containing Nanoencapsulated Fluoride, it will be collected biofilm samples 1h and 12 h after rinse; and unstimulated saliva in times of 3, 15, 30, 45, 60 minutes and 12 hours after. The data will be obtained by physical and chemical analysis of the samples of fluoride (F). Therefore, the study will consist of two interrelated steps: a clinical phase for biofilm collection and saliva; and laboratory stage for fluoride analysis in the samples. Will be conducted pilot test with three participants before the start of the study. Sample Size The sample size calculation was performed using fluoride concentration data in dental biofilm previous study and taking effect size difference between the experimental mouthwash (100% Nanoencapsulated Fluoride ) and positive control of at least 3.4 ppm of F- in biofilm after 12 hours, namely, 25%. Admitting experimental protocol with beta error of 10% alpha error of 5%, one-tailed and statistical power of 90%, the sample size was calculated for 6 people. For the calculation we used the Excel software and mathematical formula for clinical trials of superiority given. Adding sample loss resulted in 12 people. Experimental Mouthwash For this study will be used four mouthwashes: 50% Nanoencapsulated Fluoride, 100% Nanoencapsulated Fluoride, Free sodium fluoride, Without fluoride. The mouthwash, made available by the company from Brazil are packed in the same packaging and have the taste of mint. Except wash out the packing with mouthwash will be identified by letters (A, B and C) by an independent researcher. The letters code will not be revealed to the participants nor the researcher who will accompany them. These will be drawn at random for daily use for seven days in four times, giving an interval of one week wash-out between them. In these periods of wash-out will use a mouthwash without fluoride. In the end, all study participants will use the 5 experimental mouthwash at different times. A dentifrice without fluoride will be used by the participant during the study. Clinical phase The participant will be informed about the study and after its acceptance, he/she will initiate the study. Initially will be clinical examination in order to report the presence of any of the exclusion criteria already listed. After verifying the absence of these criteria, there will be a dental prophylaxis pumice for removal of this biofilm and in some cases may be made supragingival scraping. The patient will be advised not to make use of any fluoride product during the experiment. At first, volunteers are instructed to use a mouthwash without fluoride (wash out) the first week, in order to equate the study participants and eliminate any potential carryover effects of toothpaste or mouthwash used previously. The participant will get a packing of mouthwash and will be instructed to brush their teeth for 1 minute with the dentifrice without fluoride and rinse with 10 mL of mouthwash for 1 min twice a day (morning and night). On the seventh day, the participant will be instructed to brush only the occlusal surfaces of your teeth, to allow biofilm accumulation of flat surfaces, and rinse with the mouthwash. When going to bed, you are warned not to eat or drink (except water) as well as not brushing your teeth until the next day. On the following morning, approximately 12 hours after the last brushing and fasting, the first dental biofilm sample and unstimulated saliva is collected. It will be used to remove biofilm Hollenback vestibular faces, interproximal, palatal and lingual right hemiarch and deposited in a pre-weighed Eppendorf tube in an analytical balance. To saliva collection, the participant, at rest, will be instructed to spit for a minute in a graduated glass tube. After that, the participant will brush the occlusal surfaces for 1 min and rinse with 10 mL of the mouthwash for 1 min. Soon after, will new collection of saliva and plaque. Saliva samples will give up in times of 3, 15, 30, 45 and 60 minutes after brushing, while the biofilm left hemiarch will be collected one hour after brushing. After the collection will be offered at breakfast organized by researchers participating in the crown of that research center. Laboratorial phase Samples will be evaluated through physical-chemical analysis of fluoride using calibrated fluoride electrode. Samples will be analyzed for fluoride concentration using ion-specific electrode after diffusion facilitated with hexamethyl disiloxane (HMDS). The calibration curve is made for each analysis. All analyzes will be done in triplicate and be submitted for validation. Data analysis The study data will be analyzed by inferential statistics considering p <0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries
Keywords
Fluoride, Dental caries, Mouthwashes

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Model Description
A randomized, triple-blind crossover clinical trial study was performed to evaluate the bioavailability of intraoral fluoride in biomarkers of exposure (biofilm and saliva) after the use of mouthwash with experimental fluoride for one week, with wash-out periods between them
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Mouthwash without fluoride.
Arm Title
Mouthwash standard
Arm Type
Active Comparator
Arm Description
Mouthwash with 225ppm sodium fluoride (NaF). Positive control.
Arm Title
Mouthwash 50% Nano-F
Arm Type
Experimental
Arm Description
Mouthwash experimental with Fluoride being half of fluoride Nanoencapsulated and other half freeform of NaF.
Arm Title
Mouthwash 100% Nano-F
Arm Type
Experimental
Arm Description
Mouthwash experimental with fluoride 100% Nanoencapsulated.
Intervention Type
Other
Intervention Name(s)
Mouthwash 100% Nano-F
Intervention Description
Use 10 ml of mouthwash 100% Nanoencapsulated Fluoride after brushing for one week, twice a day.
Intervention Type
Other
Intervention Name(s)
Mouthwash 50% Nano-F
Intervention Description
Use 10 ml of mouthwash 50% Nanoencapsulated Fluoride after brushing for one week, twice a day.
Intervention Type
Other
Intervention Name(s)
Mouthwash standard
Intervention Description
Use 10 ml of mothwash after brushing for one week, twice a day. It's for the positive control of fluoride.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Use 10 ml of mouthwash without fluoride
Primary Outcome Measure Information:
Title
Bioavailability of intraoral fluoride (biofilm and saliva) collection of dental plaque(biofilm) and saliva
Time Frame
six months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
32 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: resident in João Pessoa; Decayed, Missing, Filled Index<6; Healthy Exclusion Criteria: orthodontic treatment; gingivitis; Periodontal disease; Smokers; Present active tooth decay; Tooth sensitivity; Those undergoing treatment with fluoride products and / or use of antimicrobials in the past four weeks
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fábio Sampaio
Organizational Affiliation
University Federal of Paraiba
Official's Role
Study Director
Facility Information:
Facility Name
Federal University of Paraíba
City
João Pessoa
State/Province
Paraíba
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Time Frame
January 2022 - January 2024
IPD Sharing Access Criteria
free
Citations:
PubMed Identifier
19365118
Citation
Buzalaf MA, Vilhena FV, Iano FG, Grizzo L, Pessan JP, Sampaio FC, Oliveira RC. The effect of different fluoride concentrations and pH of dentifrices on plaque and nail fluoride levels in young children. Caries Res. 2009;43(2):142-6. doi: 10.1159/000211717. Epub 2009 Apr 8.
Results Reference
result
PubMed Identifier
12218274
Citation
Whitford GM, Wasdin JL, Schafer TE, Adair SM. Plaque fluoride concentrations are dependent on plaque calcium concentrations. Caries Res. 2002 Jul-Aug;36(4):256-65. doi: 10.1159/000063931.
Results Reference
result
PubMed Identifier
18434577
Citation
Pessan JP, Silva SM, Lauris JR, Sampaio FC, Whitford GM, Buzalaf MA. Fluoride uptake by plaque from water and from dentifrice. J Dent Res. 2008 May;87(5):461-5. doi: 10.1177/154405910808700501.
Results Reference
result
PubMed Identifier
25045768
Citation
Pessan JP, Pinto Alves KM, Italiani Fde M, Ramires I, Lauris JR, Whitford GM, Toumba KJ, Robinson C, Buzalaf MA. Distribution of fluoride and calcium in plaque biofilms after the use of conventional and low-fluoride dentifrices. Int J Paediatr Dent. 2014 Jul;24(4):293-302. doi: 10.1111/ipd.12073.
Results Reference
result
PubMed Identifier
25677244
Citation
Pessan JP, Conceicao JM, Grizzo LT, Szekely M, Fazakas Z, Buzalaf MA. Intraoral fluoride levels after use of conventional and high-fluoride dentifrices. Clin Oral Investig. 2015 May;19(4):955-8. doi: 10.1007/s00784-015-1426-3. Epub 2015 Feb 14.
Results Reference
result
PubMed Identifier
25634162
Citation
Duckworth RM, Jones S. On the relationship between the rate of salivary flow and salivary fluoride clearance. Caries Res. 2015;49(2):141-6. doi: 10.1159/000365949. Epub 2015 Jan 27.
Results Reference
result
PubMed Identifier
1592970
Citation
Duckworth RM, Morgan SN, Gilbert RJ. Oral fluoride measurements for estimation of the anti-caries efficacy of fluoride treatments. J Dent Res. 1992 Apr;71 Spec No:836-40. doi: 10.1177/002203459207100S09.
Results Reference
result

Learn more about this trial

Evaluation in Vivo of Mouthwash With Nanoencapsulated Fluoride

We'll reach out to this number within 24 hrs